1. Home
  2. XBIT vs NNBR Comparison

XBIT vs NNBR Comparison

Compare XBIT & NNBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.41

Market Cap

75.0M

Sector

Health Care

ML Signal

HOLD

Logo NN Inc.

NNBR

NN Inc.

HOLD

Current Price

$2.18

Market Cap

75.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBIT
NNBR
Founded
2005
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
75.0M
75.8M
IPO Year
2015
1996

Fundamental Metrics

Financial Performance
Metric
XBIT
NNBR
Price
$2.41
$2.18
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
21.3K
1.1M
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.60
EPS
N/A
N/A
Revenue
N/A
$770,657,000.00
Revenue This Year
N/A
$8.60
Revenue Next Year
N/A
$6.30
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.09
$1.10
52 Week High
$3.61
$2.99

Technical Indicators

Market Signals
Indicator
XBIT
NNBR
Relative Strength Index (RSI) 38.96 47.28
Support Level $2.35 $1.80
Resistance Level $2.41 $2.24
Average True Range (ATR) 0.06 0.19
MACD -0.02 -0.07
Stochastic Oscillator 4.00 2.83

Price Performance

Historical Comparison
XBIT
NNBR

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

About NNBR NN Inc.

NN Inc is a diversified industrial company that combines engineering and production capabilities with materials science expertise to design and manufacture high-precision components and solutions. The company operates through two segments: Mobile Solutions, which generates maximum revenue and focuses on the automotive, general industrial, and medical end markets, manufacturing tight-tolerance components used in battery electric, hybrid electric, and internal combustion engine vehicles, braking, transmissions, fuel systems, HVAC, and diesel systems; and Power Solutions, which focuses on the electrical, general industrial, automotive, medical, and aerospace and defense end markets and manufactures high-precision metal components, assemblies, contact assemblies, and precision stampings.

Share on Social Networks: